Regulation of Metabolic Activity by p53

被引:61
作者
Floeter, Jessica [1 ]
Kaymak, Irem [1 ]
Schulze, Almut [1 ,2 ]
机构
[1] Theodor Boveri Inst, Bioctr, Dept Biochem & Mol Biol, Hubland, D-97074 Wurzburg, Germany
[2] Comprehens Canc Ctr Mainfranken, Josef Schneider Str 6, D-97080 Wurzburg, Germany
关键词
cancer metabolism; p53 tumour suppressor; fatty acid metabolism; cholesterol; microenvironment; PROMOTES CELL-SURVIVAL; ONE-CARBON METABOLISM; TUMOR-SUPPRESSOR P53; FATTY-ACID OXIDATION; PYRUVATE-KINASE M2; WILD-TYPE P53; LIPID-METABOLISM; MUTANT P53; HUMAN CANCER; P53-INDUCIBLE REGULATOR;
D O I
10.3390/metabo7020021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Metabolic reprogramming in cancer cells is controlled by the activation of multiple oncogenic signalling pathways in order to promote macromolecule biosynthesis during rapid proliferation. Cancer cells also need to adapt their metabolism to survive and multiply under the metabolically compromised conditions provided by the tumour microenvironment. The tumour suppressor p53 interacts with the metabolic network at multiple nodes, mostly to reduce anabolic metabolism and promote preservation of cellular energy under conditions of nutrient restriction. Inactivation of this tumour suppressor by deletion or mutation is a frequent event in human cancer. While loss of p53 function lifts an important barrier to cancer development by deleting cell cycle and apoptosis checkpoints, it also removes a crucial regulatory mechanism and can render cancer cells highly sensitive to metabolic perturbation. In this review, we will summarise the major concepts of metabolic regulation by p53 and explore how this knowledge can be used to selectively target p53 deficient cancer cells in the context of the tumour microenvironment.
引用
收藏
页数:18
相关论文
共 138 条
[1]   Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant Responses [J].
Anastasiou, Dimitrios ;
Poulogiannis, George ;
Asara, John M. ;
Boxer, Matthew B. ;
Jiang, Jian-kang ;
Shen, Min ;
Bellinger, Gary ;
Sasaki, Atsuo T. ;
Locasale, Jason W. ;
Auld, Douglas S. ;
Thomas, Craig J. ;
Vander Heiden, Matthew G. ;
Cantley, Lewis C. .
SCIENCE, 2011, 334 (6060) :1278-1283
[2]   ROS-Mediated p53 Induction of Lpin1 Regulates Fatty Acid Oxidation in Response to Nutritional Stress [J].
Assaily, Wissam ;
Rubinger, Daniel A. ;
Wheaton, Keith ;
Lin, Yunping ;
Ma, Weili ;
Xuan, Wanli ;
Brown-Endres, Lauren ;
Tsuchihara, Katsuya ;
Mak, Tak W. ;
Benchimol, Samuel .
MOLECULAR CELL, 2011, 44 (03) :491-501
[3]  
Atsumi T, 2002, CANCER RES, V62, P5881
[4]   TIGAR, a p53-inducible regulator of glycolysis and apoptosis [J].
Bensaad, Karim ;
Tsuruta, Atsushi ;
Selak, Mary A. ;
Calvo Vidal, M. Nieves ;
Nakano, Katsunori ;
Bartrons, Ramon ;
Gottlieb, Eyal ;
Vousden, Karen H. .
CELL, 2006, 126 (01) :107-120
[5]   Modulation of intracellular ROS levels by TIGAR controls autophagy [J].
Bensaad, Karim ;
Cheung, Eric C. ;
Vousden, Karen H. .
EMBO JOURNAL, 2009, 28 (19) :3015-3026
[6]   Regulation of Monocarboxylate Transporter MCT1 Expression by p53 Mediates Inward and Outward Lactate Fluxes in Tumors [J].
Boidot, Romain ;
Vegran, Frederique ;
Meulle, Aline ;
Le Breton, Aude ;
Dessy, Chantal ;
Sonveaux, Pierre ;
Lizard-Nacol, Sarab ;
Feron, Olivier .
CANCER RESEARCH, 2012, 72 (04) :939-948
[7]   Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion [J].
Bourdon, Alice ;
Minai, Limor ;
Serre, Valerie ;
Jais, Jean-Philippe ;
Sarzi, Emmanuelle ;
Aubert, Sophie ;
Chretien, Dominique ;
de Lonlay, Pascale ;
Paquis-Flucklinger, Veronique ;
Arakawa, Hirofumi ;
Nakamura, Yusuke ;
Munnich, Arnold ;
Rotig, Agnes .
NATURE GENETICS, 2007, 39 (06) :776-780
[8]   p53 target genes Sestrin1 and Sestrin2 connect genotoxic stress and mTOR signaling [J].
Budanov, Andrei V. ;
Karin, Michael .
CELL, 2008, 134 (03) :451-460
[9]   Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD [J].
Budanov, AV ;
Sablina, AA ;
Feinstein, E ;
Koonin, EV ;
Chumakov, PM .
SCIENCE, 2004, 304 (5670) :596-600
[10]   Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth [J].
Buzzai, Monica ;
Jones, Russell G. ;
Amaravadi, Ravi K. ;
Lum, Julian J. ;
DeBerardinis, Ralph J. ;
Zhao, Fangping ;
Viollet, Benoit ;
Thompson, Craig B. .
CANCER RESEARCH, 2007, 67 (14) :6745-6752